This inventor holds 5 USPTO granted patents. Top assignees: The Burnham Institute, Burnham Institute for Medical Research. Active years: 2003-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2003 - 2008)
- La Jolla, CA (US) (2009 - 2011)
Company Filing History:
Years Active: 2003-2011
Title: Innovations of Shu-ichi Matsuzawa
Introduction
Shu-ichi Matsuzawa is a prominent inventor based in San Diego, California. He has made significant contributions to the field of protein degradation, holding a total of 5 patents. His work focuses on novel proteins and methods that have potential applications in therapeutic compositions and drug screening.
Latest Patents
Matsuzawa's latest patents include innovations related to nucleic acids encoding proteins involved in protein degradation. His inventions introduce novel Siah-Mediated-Degradation-Proteins (SMDPs) and SCF-Complex Proteins (SCPs). These proteins can be utilized in various applications, such as producing antibodies for therapeutic use and conducting drug screening. Additionally, his patents describe methods for targeting the destruction of specific polypeptides in eukaryotic cells, leveraging the ubiquitin-independent mechanism of degradation by the 26S proteasome.
Career Highlights
Throughout his career, Matsuzawa has worked with esteemed institutions, including the Burnham Institute and the Burnham Institute for Medical Research. His research has significantly advanced the understanding of protein degradation mechanisms and their implications in various biological processes.
Collaborations
Matsuzawa has collaborated with notable professionals in his field, including John C. Reed. These partnerships have fostered innovation and contributed to the development of groundbreaking research in protein biology.
Conclusion
Shu-ichi Matsuzawa's contributions to the field of protein degradation exemplify the impact of innovative research on therapeutic applications. His patents and collaborations continue to influence advancements in biotechnology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

